Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05468463 · ClinicalTrials.gov registry record · NA

Promoting Increases in Living Donation Via Tele-navigation (PILOT)

A NA study of Kidney Diseases, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
347
Enrollment target
1
Study location

NCT05468463 is a NA study of Kidney Diseases that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 347 participants, below the 1,776-participant average among 38 other Kidney Diseases trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05468463, a NA study of Kidney Diseases, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
347 participants
Enrollment target
1
Study location

Study Summary

We hypothesize that expansion of the Living Donor Navigator (LDN) program to include tele-health delivery will overcome geographic disparities in access and facilitate sustained increases in living donation. We will utilize an individually randomized group trial (IRGT) design with delayed intervention initiation to compare the effectiveness of tele-health LDN model to standard of care.

Conditions Studied

Interventions

  • BEHAVIORAL Living Donor Navigator Program

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 347 participants
Start Date 2023-04-12
Est. Completion 2026-07-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05468463

The ClinicalTrials.gov registry entry for NCT05468463 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 347 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,776-participant average among 38 other Kidney Diseases trials with a reported enrollment target (80% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Living Donor Navigator Program is the first listed.

NCT05468463 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05468463 about?

NCT05468463 is a clinical study titled "Promoting Increases in Living Donation Via Tele-navigation (PILOT)". We hypothesize that expansion of the Living Donor Navigator (LDN) program to include tele-health delivery will overcome geographic disparities in access and facilitate sustained increases in living donation. We will utilize an individually randomized group trial (IRGT) design with delayed interventi...

What is the current status of trial NCT05468463?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 347 participants. The study started on 2023-04-12. Estimated completion is 2026-07-31.

What conditions does trial NCT05468463 study?

This clinical trial studies the following conditions: Kidney Diseases.

What interventions are being tested in trial NCT05468463?

The interventions under investigation include: Living Donor Navigator Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05468463?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05468463 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.